目前越来越多的冠状动脉性心脏病患者接受了经皮冠状动脉介入治疗,药物支架也已成为介入治疗的焦点。通过对药物支架和裸支架的比较,指出了药物支架的特点和优势,以及药物支架发展至今其安全性的争议和研究进展,并预测了其未来的发展方向。随着药物支架的不断发展,介入心脏病学必将会迎来更多的革命。药物支架取代裸支架是一种必然的趋势,可降解支架的发展则是新的里程碑。 At present, more and more patients with coronary heart disease have undergone percutaneous coronary intervention, and drug stents have also become the focus of interventional therapy. By comparing the scaffolds with bare scaffolds, the characteristics and advantages of scaffolds, the controversy and research progress of their scaffolds, and their future development are predicted. With the continuous development of drug stents, interventional cardiology will surely usher in more revolutions. The replacement of bare scaffolds with drug scaffolds is an inevitable trend, and the development of degradable scaffolds is a new milestone.